Therapeutic Drugs

Therapeutic Drugs

In 2012 T.A. Sciences® acquired the worldwide rights to a new patent-pending compound that has the potential to prevent or treat many diseases associated with aging

This exciting drug candidate has already undergone various enabling studies required by the U.S. Food and Drug Administration (FDA) to file an Investigational New Drug Application (INDA).

T.A. Sciences’® 2019 research plan includes funding to continue this promising project. It is the company’s intention to develop products that can address many diseases associated with aging.

Therapeutic drugs utilizing the patented compound will require full FDA approval before they can be sold to the public. It will take many years and much more investment before T.A. Sciences® will possibly introduce an FDA-approved drug.

Please check back here for more updates on our progress in developing therapeutic drugs.

Toll-Free: 888.360.8886
×

Give Yourself

or someone else a gift of longer telomeres!

get TA-65MD ®   for as low as

$49. 99


By submitting this form, you are consenting to receive marketing emails from: Telomerase Activation Sciences, Inc., 420 Lexington Ave, New York, NY, 10170, http://www.tasciences.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

ends in the next

check your email for offer details